Smallcap and microcap investors have to be willing to search the entire globe and explore every possible industry to find the hidden gems that can provide the outsized returns that are possible in the space. On rare occasions, a new industry is created either through technological innovation or changes in government regulation. One such industry is the Canadian cannabis market, which has opened up in recent years and is a young sector with the potential for outsized growth. The space is crowded right now as there is somewhat of a gold rush atmosphere, so finding the companies that are poised to be long-term winners is a difficult but worthwhile endeavor.
One potential winner is Ayurcann Holdings (CSE: AYUR) (OTCQB: AYURF) which is a diversified outsourcing service provider to the Canadian cannabis market. The company’s services include white labeling, oil extraction and refinement, bulk oil distillate sales, packaging solutions, inventory management, and medical cannabis products such as tinctures, topical solutions, and vapes.
The recreational cannabis market in Canada was $2.6 billion in 2020 and is estimated to grow to $8.6 billion by 2026 according to Statista. In addition to a favorable macro environment, Ayurcann has a few catalysts working in its favor. The company recently received government approval to grow their plants which should improve margins as they integrate their supply chain and should not have to rely on buying plants from other firms. Recent market expansion should also provide upside, as the company now sells products in Alberta, Ontario, Saskatchewan, New Brunswick, and Manitoba. Previously they only were able to see in New Brunswick and Saskatchewan, but now Canada’s biggest markets are in the company’s footprint.
In the most recent quarter, fiscal 2Q 2022 (ended December 2021) the company reported accelerating revenue, which was up 106% year over year to come in at $3.2 million. Gross margin and EBITDA are also on the upswing, coming in at 56% and 25%, respectively, for the same period. Strong performance in the white labeled products category should offset softness in the oil distillate category and the expanded market footprint should be a major driver of results going forward. The white labeling category is especially attractive as it functions like a toll collecting business where Ayurcann can simply collect its fees and not have to be concerned with branding.
The sector and company certainly have risks involved. The cannabis industry is still in a bit of a wild west phase currently, with numerous market participants entering and exiting the space rapidly. The sector is still young enough where the dominant players have yet to be established, so there is a horserace atmosphere still. The company is a penny stock, and such low-priced stocks can fluctuate wildly so investors need to exercise care and take their time building (or reducing) positions so as not to cause big swings in the price. If however, Ayurcann can continue its expansion into new markets and successfully expand its product portfolio, the company is poised to be one of the winners in a new and growing industry.
Spotlight Growth is compensated, either directly or via a third party, to provide investor relations services for its clients. Spotlight Growth creates exposure for companies through a customized marketing strategy, including design of promotional material, the drafting and editing of press releases and media placement.
All information on featured companies is provided by the companies profiled, or is available from public sources. Spotlight Growth and its employees are not a Registered Investment Advisor, Broker Dealer or a member of any association for other research providers in any jurisdiction whatsoever and we are not qualified to give financial advice. The information contained herein is based on external sources that Spotlight Growth believes to be reliable, but its accuracy is not guaranteed. Spotlight Growth may create reports and content that has been compensated by a company or third-parties, or for purposes of self-marketing. Spotlight Growth was compensated one thousand dollars cash for the creation and dissemination of this content by a third party Guerrilla Capital and Ryan Yanch.
This material does not represent a solicitation to buy or sell any securities. Certain statements contained herein constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements may include, without limitation, statements with respect to the Company’s plans and objectives, projections, expectations and intentions. These forward-looking statements are based on current expectations, estimates and projections about the Company’s industry, management’s beliefs and certain assumptions made by management.
The above communication, the attachments and external Internet links provided are intended for informational purposes only and are not to be interpreted by the recipient as a solicitation to participate in securities offerings. Investments referenced may not be suitable for all investors and may not be permissible in certain jurisdictions.
Spotlight Growth and its affiliates, officers, directors, and employees may have bought or sold or may buy or sell shares in the companies discussed herein, which may be acquired prior, during or after the publication of these marketing materials. Spotlight Growth, its affiliates, officers, directors, and employees may sell the stock of said companies at any time and may profit in the event those shares rise in value. For more information on our disclosures, please visit: https://spotlightgrowth.com/disclosures/
Source: SpotLight Growth Canabis
Ayurcann (CSE: AYUR) (OTCQB: AYURF) Continues Expansion Across Canada, Seeing Strong Growth Despite Cannabis Industry Challenges
SpotLight Growth Canabis